AN OPEN-LABEL MULTICENTER STUDY OF GABAPENTIN (NEURONTIN) MONOTHERAPY AND SAFETY IN MEDICALLY REFRACTORY PATIENTS WITH PARTIAL SEIZURES

被引：0
|
作者：
HAYES, A
HES, MK
MANN, M
GAROFALO, E
LEIDERMAN, DB
PIERCE, M
机构：
来源：
NEUROLOGY | 1994年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A204 / A204
页数：1
相关论文
共 50 条
  • [21] GABAPENTIN (NEURONTIN) AS MONOTHERAPY IN NEWLY-DIAGNOSED PATIENTS WITH PARTIAL EPILEPSY
    ANHUT, H
    GREINER, M
    MOCKEL, V
    MURRAY, G
    EPILEPSIA, 1995, 36 : S119 - S119
  • [22] Open-label efficacy and safety of levetiracetam in pediatric patients with partial onset seizures
    Glauser, T
    Bebin, M
    Ritter, F
    Nohria, V
    Jensen, C
    EPILEPSIA, 1999, 40 : 161 - 162
  • [23] Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study
    Song, Yuqin
    Song, Yongping
    Liu, Lihong
    Zhang, Mingzhi
    Li, Zhiming
    Ji, Chunyan
    Xu, Wei
    Liu, Ting
    Xu, Bing
    Wang, Xin
    Gao, Sujun
    Zhang, Huilai
    Hu, Yu
    Li, Yan
    Cheng, Ying
    Yang, Haiyan
    Cao, Junning
    Zhu, Zunmin
    Hu, Jianda
    Zhang, Wei
    Jing, Hongmei
    Ding, Kaiyang
    Lu, Zhengguang
    Zhang, Bin
    Zhao, Renbin
    Xu, Zhixin
    Zhu, Jun
    BLOOD, 2019, 134
  • [24] A multicenter, outpatient, open-label study to evaluate the dosing and safety of topiramate monotherapy for epilepsy
    Sankar, Raman
    Ramsay, R. E.
    Wiegand, F.
    Zhu, Y.
    Hulihan, J. F.
    Mckay, A.
    EPILEPSIA, 2007, 48 : 370 - 370
  • [25] Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study
    Beran, RG
    Berkovic, SF
    Black, AB
    Danta, G
    Hiersemenzel, R
    Schapel, GJ
    Vajda, FJE
    EPILEPSY RESEARCH, 2005, 63 (01) : 1 - 9
  • [26] Safety and efficacy of open-label rufinamide as adjunctive therapy in pediatric patients with partial seizures
    Litzinger, MJ
    Hanny, A
    EPILEPSIA, 1999, 40 : 114 - 114
  • [27] Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: A multicenter open-label single-arm trial in Korean patients
    Heo, Kyoung
    Lee, Byung In
    Do Yi, Sang
    Cho, Yong Won
    Shin, Dong Jin
    Song, Hong Ki
    Kim, Ok Joon
    Park, Sung-Pa
    Kim, Sung Eun
    Kim, Sang Ho
    Lee, Jun Hong
    Kim, Kyu-Sik
    Lee, Se-Jin
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2012, 21 (03): : 188 - 193
  • [28] Efficacy and safety of levetiracetam in children with partial seizures: An open-label trial
    Glauser, TA
    Pellock, JM
    Bebin, EM
    Fountain, NB
    Ritter, FJ
    Jensen, CM
    Shields, WD
    EPILEPSIA, 2002, 43 (05) : 518 - 524
  • [29] Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial
    Vossler, David G.
    Wechsler, Robert T.
    Williams, Paulette
    Byrnes, William
    Therriault, Sheila
    EPILEPSIA, 2016, 57 (10) : 1625 - 1633
  • [30] Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, registration directed Phase II study
    Fowler, Nathan H.
    Samaniego, Felipe
    Jurczak, Wojciech
    Lech-Maranda, Ewa
    Ghosh, Nilanjan
    Anz, Bertrand
    Patten, Piers
    Reeves, James A.
    Leslie, Lori A.
    Smolewski, Piotr
    Chavez, Julio C.
    Ghia, Paolo
    Tarella, Corrado
    Burke, John M.
    Sharman, Jeff
    Kolibaba, Kathryn
    O'Connor, Owen A.
    Cheah, Chan Y.
    Miskin, Hari P.
    Sportelli, Peter
    Weiss, Michael S.
    Zinzani, Pier Luigi
    CANCER RESEARCH, 2019, 79 (13)
12345